STOCK TITAN
  1. Home
  2. PHXM

PHAXIAM THERAPEUTICS S A (PHXM) Stock Price, News & Analysis

PHXM NASDAQ

Company Description

PHAXIAM THERAPEUTICS S A (NASDAQ: PHXM) is classified in the biological product (except diagnostic) manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for PHXM, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
6.1M
Shares outstanding

Latest News

View All
—

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024

—

PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area

—

PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day"

—

PHAXIAM Reports Third-Quarter 2024 Financial Information

—

Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2024

—

PHAXIAM Therapeutics Receives FDA Clearance to Initiate Phase II GLORIA Study in the U.S.

clinical trial fda approval

PHAXIAM THERAPEUTICS S A has 10 recent news articles. Key topics include clinical trial, fda approval. View all PHXM news →

SEC Filings

View All

No SEC filings available for PHXM.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PHXM Company Profile & Sector Positioning

PHAXIAM THERAPEUTICS S A (PHXM) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.